Trials / Completed
CompletedNCT05936892
Comparative Effects of UE Aerobic and Resistance Training on Cardiorespiratory Fitness in Hypertensive Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
simple random sampling into group A \& group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life.
Detailed description
A randomized clinical trial will be conducted at Multan institute of cardiology, Multan. Non probability convenient sampling technique will be applied on--patients who will be allocated through simple random sampling into group A \& group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life. Data will be analyzed using SPSS software version 25. After assessing normality of data by Shapiro-wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | upper extremity aerobic training | upper extremity aerobic training \& baseline treatment will be given. Overall session time will be 40-45 minutes |
| OTHER | upper extremity resistance training | upper extremity resistance training Overall session time will be 40-45 minutes |
Timeline
- Start date
- 2023-06-15
- Primary completion
- 2023-08-10
- Completion
- 2023-11-20
- First posted
- 2023-07-10
- Last updated
- 2024-06-13
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05936892. Inclusion in this directory is not an endorsement.